Prelude Capital Management, LLC Mannkind Corp Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $4,967 - $8,567	-4,557 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $5,194 - $10,253	4,557 New	4,557 $9,000
Q4 2017 Feb 14, 2018	SELL	$2.28 - $6.71 $24,623 - $72,468	-10,800 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $12,419 - $24,732	10,800	10,800 $23,000

219

133M

1.43M

851K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.71B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.